EGFR and breast cancer: For breast cancer, the most common therapeutic targets are CEA, CD70, ROR1, HER2, MUC1, EGFR, CD133, MSLN, EpCAM, disialoganglioside (GD2), and the hepatocyte growth factor receptor (HGFR) (153, 154).